Warberg Asset Management LLC Tc Bio Pharm (Holdings) PLC Transaction History

Warberg Asset Management LLC

  • $12.6 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
SELL
$0.26 - $2959.0 $22,532 - $256 Million
-86,665 Reduced 87.39%
12,500 $4,000
Q2 2022

Aug 11, 2022
BUY
$0.34 - $1.67 $33,716 - $165,605
99,165 New
99,165 $36,000

About TC BioPharm (Holdings) plc

TCBP Quotes by TradingView
  • Ticker TCBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,747,700
  • Market Cap $28.2M
  • Description
  • TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19...
More about TCBP
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email